Skip to main content

Table 3 Clinical characteristics: treatments and their side effects

From: Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France

 

Drugs

N (%)

Side effectsa

N (%)

Mean number of drugs/side effects per patient

6.6 ± 1.8 (2–14)

6.4 ± 1.7 (4–9)

Immunosuppressive treatments

1397 (98.1)

344 (24.6)

 Calcineurin inhibitors

1170 (82.2)

242 (20.6)

 Mycophenolic acid and derivatives

933 (65.5)

115 (12.3)

 Corticoids

832 (58.4)

159 (19.1)

 Others (mTOR inhibitors, Azathioprine)

334 (23.4)

56 (16.7)

Antihypertensive treatments

1161 (81.5)

72 (6.2)

 Beta-blockers

727 (51.1)

28 (3.8)

 Angiotensin-converting enzyme (ACE) inhibitors

709 (49.8)

34 (4.8)

 Calcium antagonists

485 (34.1)

20 (4.1)

 Others (Central antihypertensive, Peripheral vasodilators/alpha-blockers, Diuretics)

544 (38.2)

30 (5.5)

Other treatments

1170 (82.2)

54 (4.6)

 Cardiovascular drugs

792 (55.6)

38 (48.0)

 Calcium drugs

727 (51.1)

2 (0.3)

 Diabetes drugs

239 (16.8)

13 (5,4)

 Erythropoiesis-Stimulating Agents (ESA)

199 (14.0)

1 (0.5)

 Antidepressants

149 (10.5)

4 (2.7)

  1. aPercentage of side effects = number of patients with a side effect related to the treatment dividing by number of patients taking this treatment